BioNexus Gene Lab
BGLC
$0.60
Share price
3.21%
Change (1 day)
140.28%
Change (1 year)
Categories
BioNexus Gene Lab (BGLC) - Total liabilities
Total liabilities on the balance sheet as of December 2023 : $1.74 M
According to BioNexus Gene Lab's latest financial reports the company's total liabilities are $1.74 M. A company’s total liabilities is the sum of all current and non-current debts and obligations.
BioNexus Gene Lab - Total liabilities on balance sheet (from 2019 to 2023)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2022-12-31 | $2.07 M | -13.34% |
| 2021-12-31 | $2.39 M | -30.65% |
| 2020-12-31 | $3.45 M | 3071.74% |
| 2019-12-31 | $0.1 M | -16.45% |
| 2018-12-31 | $0.13 M |
Total liabilities for similar companies or competitors
| Company | Total liabilities | differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | $27.91 M | 1,502.75% | 🇺🇸 USA |